Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-25

Clinical Trial Update: Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical study update for JDB0131 Benzenesulfonate Tablets in drug-resistant pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JDB0131 Benzenesulfonate Tablets (JDB0131 benzenesulfonate)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Drug-resistant Tuberculosis | Phase 2 | Status: UNKNOWN